(Journal Article): Antisecretory vs. Antiproteasic Drugs in the Prevention of Post-ERCP Pancreatitis: The Evidence-Based Medicine Derived from a Meta-Analysis Study
 
Andriulli A, Caruso N, Quitadamo M, Forlano R, Leandro G, Spirito F, De Maio G
 
IN: JOP. J Pancreas (Online) 2003; 04(1):41-48

ABSTRACT: Uncertainties still exist about the clinical benefit of pharmacological prevention of post-ERCP pancreatitis by either antisecretory drugs such as somatostatin and its long-acting ... Click HERE for details